U

SynVaccine

Design and Construction of Viral-based Products
Startup Seed Founded 2013 Health Tech & Life Sciences
Last Update Sep 25, 2024

SynVaccine Business

Business models
B2B
Product stage
R&D
Employees
1-10

Sector

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Target Customer

Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology

Core Technology

Biologicals

Tags (10)

pharmaceuticalsviral-diseasesbioinformaticsvaccines-developmentdisease-managementgenomicsanimal-healthlaboratoriesvaccinesbioconvergence

Geographic Markets

Israel